Biocon (BIOCON) Share Price Rises 2.97% Today to Rs 343.70
- October 28, 2026
- Posted by: Kunal Singla
- Category: News
Biocon Share Price moved up 2.97% in today’s session, with the stock last trading at Rs 343.70 against a previous close of Rs 333.80. The gain of Rs 9.90 lifts the market capitalisation of this Healthcare company to Rs 53,250.26 crore, according to latest Univest data as of 28 October 2026 at 12:07:37 PM IST.
The Biocon Share Price Today story is one of a clear price rise inside the Pharmaceuticals & Drugs industry. Univest figures confirm the price action, but they do not point to a specific company trigger. Stock news around Biocon has not been linked to the move, so this Biocon Stock News update stays with what the numbers show.
Biocon Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 343.7 |
| Previous Close | Rs 333.8 |
| Today's Move | Rs 9.9 (+2.97%) |
| Open | Rs 332.1 |
| High | Rs 343.95 |
| Low | Rs 330.85 |
| Market Capitalisation | Rs 53,250.26 crore |
| Market Cap Category | Large Cap |
The share opened at Rs 332.10, touched a low of Rs 330.85 and a high of Rs 343.95. That keeps Biocon Share Price Live Rs 0.25 below the day’s high. Among the stocks rising today on the Indian stock market, Biocon is worth tracking for the way its intraday range developed.
Biocon Ltd. (BIOCON) rose to Rs 343.7 from the previous close of Rs 333.8, a move of Rs 9.9 or 2.97%. The stock opened at Rs 332.1, reached a high of Rs 343.95, recorded a low of Rs 330.85.
Biocon Share Price Today reads Rs 343.70, a rise of Rs 9.90 or 2.97% over the previous close of Rs 333.80. The stock opened at Rs 332.10, touched a low of Rs 330.85 and a high of Rs 343.95, so the market cap now stands at Rs 53,250.26 crore.
The price action is easiest to read in three steps. The stock first opened below the previous close, at Rs 332.10, and then touched its low of Rs 330.85, which is Rs 2.95 under the previous close of Rs 333.80. From that low, the Biocon Share Price Rise carried the stock up to Rs 343.95, a swing of Rs 13.10 inside a single session.
At Rs 343.70, the last traded price sits Rs 11.60 above the day open and Rs 0.25 under the day high. This Biocon Stock Performance snapshot therefore shows the stock trading within its day range at 12:07 PM IST, although the session is still open and the figures can change.
Biocon Ltd. (BIOCON) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 53,250.26 crore |
| P/E Ratio | 109.83x |
| P/B Ratio | 1.6x |
| ROE | 1.35% |
| ROCE | 3.26% |
| EPS | Rs 3.04 |
| Book Value Per Share | Rs 208.53 |
| Dividend Yield | 0.15% |
Biocon Ltd. (BIOCON) fundamental metrics show P/E 109.83x, P/B 1.6x, ROE 1.35%, ROCE 3.26%. Taken on their own, these numbers offer context rather than a trading signal.
Biocon Ltd. has a market capitalisation of Rs 53,250.26 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 109.83x, P/B at 1.6x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 1.35% and ROCE of 3.26%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.04, book value per share of Rs 208.53, dividend yield of 0.15%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.74x, median ROE of 11.23%, median ROCE of 13.17%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 109.83x |
| Benchmark Median P/E | 30.74x |
| Benchmark Average P/E | 43.3x |
| Benchmark P/E Range | 3.21x to 577.05x |
| Company P/B Ratio | 1.6x |
| Benchmark Median P/B | 2.71x |
| Company ROE | 1.35% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 3.26% |
| Benchmark Median ROCE | 13.17% |
| Company Market Capitalisation | Rs 53,250.26 crore |
| Benchmark Median Market Cap | Rs 696.43 crore |
Biocon Ltd. (BIOCON) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Biocon Ltd. (BIOCON) has a P/E ratio of 109.83x, which is above the benchmark median of 30.74x, a difference of +257.29%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Biocon Ltd. (BIOCON) has a ROE of 1.35%, which is below the benchmark median of 11.23%, a difference of -87.98%. Biocon Ltd. (BIOCON) has a ROCE of 3.26%, which is below the benchmark median of 13.17%, a difference of -75.25%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,18,204.09 | 34.91 | 4.88 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,40,780 | 86.02 | 14.25 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,73,828.11 | 82.48 | 9.53 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,520.92 | 25.79 | 4.32 | 19.69 | 21.39 |
| Laurus Labs Ltd. | LAURUSLABS | 1,11,304.32 | 105.74 | 20.5 | 18.31 | 18.2 |
Biocon Ltd. (BIOCON) has a P/E ratio of 109.83x compared with the displayed peer median of 82.48x. The comparison is relative and should not be read as a recommendation. Its ROE of 1.35% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 3.26% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Biocon Ltd. (BIOCON) has a market capitalisation of Rs 53,250.26 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Biocon
- Price action: the stock is up 2.97% at Rs 343.70, close to its day high of Rs 343.95.
- Intraday range: the share moved between Rs 330.85 and Rs 343.95 after opening at Rs 332.10.
- Valuation: the P/E ratio of 109.83 is above the industry median of 30.74 and above the average of 43.30.
- Returns: ROE of 1.35% and ROCE of 3.26% sit both below the benchmark medians of 11.23% and 13.17%.
- Size: a market cap of Rs 53,250.26 crore sits above the industry median of Rs 696.43 crore.
About Biocon
Biocon Ltd. is a listed company in the Healthcare sector, operating in the Pharmaceuticals & Drugs industry. It is tracked on Univest under the symbol BIOCON, and this Biocon Company Overview uses the latest Univest figures.
The company has a market capitalisation of Rs 53,250.26 crore, EPS of Rs 3.04 and a book value of Rs 208.53 per share. Its industry group, according to latest Univest data, has 199 companies, which gives the benchmark used throughout this article. Further company details such as segments and products are not part of this update.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Biocon Share Price rising today?
Ans. Univest figures confirm the price action, but they do not point to a specific company trigger. Biocon is up 2.97% at Rs 343.70 against a previous close of Rs 333.80, as of 12:07 PM IST.
What is the Biocon Share Price today?
Ans. Biocon Share Price Today is Rs 343.70, up Rs 9.90 or 2.97% from the previous close of Rs 333.80. The stock opened at Rs 332.10 and has moved between Rs 330.85 and Rs 343.95 so far.
What is the market cap of Biocon?
Ans. The Biocon Market Cap is Rs 53,250.26 crore, according to latest Univest data. Market capitalisation reflects company size rather than quality, and it sits above the industry median of Rs 696.43 crore.
What is the P/E ratio of Biocon?
Ans. The P/E ratio of Biocon is 109.83, compared with a same-industry median of 30.74 and an average of 43.30. The P/B ratio is 1.60 against a median of 2.71 for the benchmark.
What are the ROE and ROCE of Biocon?
Ans. ROE is 1.35% and ROCE is 3.26%. The industry benchmark shows a median ROE of 11.23% and a median ROCE of 13.17%, so the company figures are both below the respective medians.
What are the EPS and book value of Biocon?
Ans. EPS is Rs 3.04 and book value per share is Rs 208.53. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share, according to latest Univest data.
Does Biocon pay a dividend?
Ans. The dividend yield of Biocon is 0.15%, according to latest Univest data. Dividend yield is a historical figure relative to the current price and is not a guarantee of any future payout.
How does Biocon compare with its peers?
Ans. Against Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Laurus Labs, Biocon has a P/E ratio of 109.83, ROE of 1.35% and ROCE of 3.26%, with a market capitalisation of Rs 53,250.26 crore.
Track Biocon Share Price on Univest
Use Biocon Ltd. (BIOCON) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Users can track the live Biocon Share Price, fundamental ratios, 52-week levels and market insights for Biocon on Univest. The Univest stock page brings together price, valuation and peer data in one place, so readers can follow how the Biocon Share Price Today moves through the rest of the session.
This article is for information only. Univest does not give buy or sell ratings, target prices or forecasts, and the Biocon Share Price update above reflects the latest Univest figures at the time of writing.
